biotech
EnGene's shares crash on updated pivotal bladder cancer data
Endpoints News
May 11, 2026 · 19s listen
Listen · Endpoints News
EnGene's shares crash on updated pivotal bladder cancer data
0:00-0:19
Live · Kokoro-82M
Audio pre-rendered by Storyflo · cached + delivered from the edge
EnGene’s latest Phase 2 results on an experimental treatment for certain bladder cancer patients alarmed investors and raised concerns around the therapy’s future prospects. The Canadian biotech's shares {$ENGN} fell 80% Thursday morning after reporting ...
Share
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to Endpoints News.
Heard via Storyflo
Get audio versions of every article you read.
Pick what matters — your audio curator gets you into your daily flo.